Skip to main content
SpringerLink
Log in

Drug Interactions with Quinolone Antibacterials

  • Review Article
  • Drug Experience
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

The quinolone antibacterials are prone to many interactions with other drugs. Quinolone absorption is markedly reduced with antacids containing aluminium, magnesium and/or calcium and therapeutic failure may result.

Other metallic ion-containing drugs, such as sucralfate, iron salts, and zinc salts, can also reduce absorption.

Some of the newer quinolones inhibit the cytochrome P450 system, e.g. enoxacin, pefloxacin and ciprofloxacin. The toxicity of drugs that are metabolised by the cytochrome P450 system is enhanced by concomitant use of some quinolones. Ciprofloxacin, enoxacin and pefloxacin can increase theophylline concentrations to toxic values. The pharmacokinetics of warfarin and cyclosporin are unaffected. Ofloxacin, fleroxacin and temafloxacin have a low inhibitory effect on the cytochrome P450 system and a low interaction potential may result.

The affinity of quinolones for the γ-aminobutyric acid (GABA) receptor may induce CNS adverse effects; these effects are enhanced by some nonsteroidal anti-inflammatory drugs (NSAIDs).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Akerele JO, Okhamafe AO. Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics. Journal of Antimicrobial Chemotherapy 28: 87–94, 1991

    Article  PubMed  CAS  Google Scholar 

  • Barnett G, Segura J, de la Torre R, Carbo M. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition. European Journal of Clinical Pharmacology 39: 63–69, 1990

    Article  PubMed  CAS  Google Scholar 

  • Bednarczyk EM, Green JA, Nelson AD, Leisure GA, Little D, et al. Comparison of the effect of temafloxacin, ciprofloxacin, or placebo on cerebral blood flow, glucose and oxygen metabolism in healthy subjects by means of positron emission tomography. Clinical Pharmacology and Therapeutics 50: 165–171, 1991

    Article  PubMed  CAS  Google Scholar 

  • Bleske BE, Carver PL, Annesley TM, Bleske JRM, Moraday F. The effect of ciprofloxacin on the pharmacokinetic and ECG parameters of quinidine. Journal of Clinical Pharmacology 30: 911–915, 1990

    PubMed  CAS  Google Scholar 

  • Brouwers JRBJ. Pathophysiology and pharmacotherapy of peptic disease, Thesis, University of Amsterdam, 1981

    Google Scholar 

  • Brouwers JRBJ. Pharmacokinetics of the newer fluoroquinolones. Pharmaceutisch Weekblad — Scientific Edition 9 (Suppl.): S16–S22, 1987

    Article  PubMed  Google Scholar 

  • Brouwers JRBJ, Van Der Kam HJ, Sijtsma J, Koks CHW. Important drug interaction of oral ciprofloxacin with sucralfate, bismuth subcitrate and magnesium citrate solution. Pharmaceutisch Weekblad — Scientific Edition 11: E13, 1989

    Article  Google Scholar 

  • Brouwers JRBJ, Van Der Kam HJ, Sijtsma J, Proost JH. Important reduction of ciprofloxacin absorption by sucralfate and magnesium citrate solution. Drug Investigation 2: 197–199, 1990a

    Article  Google Scholar 

  • Brouwers JRBJ, Van Der Kam HJ, Sijtsma J, Proost JH. Decreased ciprofloxacin absorption with concomitant administration of ferrous fumarate. Pharmaceutisch Weekblad — Scientific Edition 12: 182–183, 1990b

    Article  PubMed  CAS  Google Scholar 

  • Carbo M, Segura J, De La Torre R, Badenas JM, Cami J. Effects of quinolones on caffeine disposition. Clinical Pharmacology and Therapeutics 45: 234–240, 1989

    Article  PubMed  CAS  Google Scholar 

  • Carpentier P, Granneman R. Lack of interaction between temafloxacin and theophylline in patients during treatment in clinical trials. 17th International Congress of Chemotherapy, Berlin, June 23–28, Abstract no. 410, 1991

  • Chodosh S, Siepman N. Influence of quinolones on theophylline levels in patients with lower respiratory tract infections. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 29–October 2. Abstract no. 880, 1991

  • Davey PG, Overview of drug interactions with quinolones. Journal of Antimicrobial Chemotherapy 22(Suppl. C): 97–107, 1988

    PubMed  CAS  Google Scholar 

  • Edwards DJ, Bowles SK, Svensson CK, Rybak MJ. Inhibition of drug metabolism by quinolone antibiotics. Clinical Pharmacokinetics 15: 194–204, 1988

    Article  PubMed  CAS  Google Scholar 

  • Eliopoulos GM, Eliopoulos CT. Ciprofloxacin in combination with other antimicrobials. American Journal of Medicine 87(Suppl. 5A): 175–225, 1989

    Google Scholar 

  • Fantin B, Carbon C. Combination of quinolones with other antibiotics in animal models. Quinolones Bulletin 7: 7–9, 1991

    Google Scholar 

  • Flor S, Guay DRP, Opsahl JA, Tack K, Matzke GR. Effect of magnesium-aluminium hydroxide and calcium carbonate antacids on bioavailability of ofloxacin. Antimicrobial Agents and Chemotherapy 34: 2436–2438, 1990

    Article  PubMed  CAS  Google Scholar 

  • Foster T, Blouin R. The effect of antacid timing on lomefloxacin bioavailability. Pharmacotherapy 11: 101, 1991

    Google Scholar 

  • Gardner SF, Green JA, Bednarczyk EM, Nelson AD, Leisure G, et al. An assessment of cerebral blood flow and metabolism after fleroxacin therapy. Journal of Clinical Pharmacology 31: 151–157, 1991

    PubMed  CAS  Google Scholar 

  • Garrelts JC, Godley PJ, Peterie JD, Gerlach EH, Yakshe CC. Sucralfate significantly reduces ciprofloxacin concentrations in serum. Antimicrobial Agents and Chemotherapy 34: 931–933, 1990

    Article  PubMed  CAS  Google Scholar 

  • Gerritsen WR, Peters A, Henny FC, Brouwers JRBJ. Ciprofloxacin induced nephrotoxicity. Nephrology Dialysis Transplantation 2: 382, 1987

    CAS  Google Scholar 

  • Golper TA, Hartstein AI, Morthland VH, Christensen JM. Effects of antacids and dialysate dwell times on multiple dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy 31: 1787–1790, 1987

    Article  PubMed  CAS  Google Scholar 

  • Grabenstein JD. Drug interactions involving immunologic agents part I: vaccine-vaccine, vaccin-immunoglobulin and vaccin-drug interactions. DICP: Annals of Pharmacotherapy 24: 67–81, 1990

    PubMed  CAS  Google Scholar 

  • Grasela TH, Schentag JJ, Sedman AJ, Wilton JH, Thomas DJ, et al. Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrobial Agents and Chemotherapy 33: 615–617, 1989

    Article  PubMed  CAS  Google Scholar 

  • Harder S, Fuhr U, Staib AH, Wolff T. Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations. American Journal of Medicine 87(Suppl. 5A): 89S–97S, 1989

    Article  PubMed  CAS  Google Scholar 

  • Harder S, Staib AH, Beer C, Papenburg A, Stille W, et al. 4-Quinolones inhibit biotransformation of caffeine. European Journal of Clinical Pharmacology 35: 651–656, 1988

    Article  PubMed  CAS  Google Scholar 

  • Healy DP, Schoenle JR, Stotka J, Polk RE. Lack of interaction between lomefloxacin and caffeine in normal volunteers. Antimicrobial Agents and Chemotherapy 35: 660–664, 1991

    Article  PubMed  CAS  Google Scholar 

  • Hori S, Shimada J, Sakai O, Matsuda M. Effect of OPC-17116, a newly synthesized quinolone on gamma-aminobutyric acid receptor binding: a comparative study of epileptogenic activity of quinolones. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 29–October 2. Abstract no. 1480, 1991

  • Hori S, Shimada J, Saito A, Matsuda M, Miyahara T. Comparison of the inhibitory effects of new quinolones on gamma-aminobutyric acid receptor binding in the presence of anti-inflammatory drugs. Review of Infectious Diseases 11(Suppl. 5): 22, 1989

    Google Scholar 

  • Hulisz D, Miller K. Update on quinolone drug interactions: sucralfate, theophylline and antacids can affect the bioavailability of quinolones. American Pharmacy NS30: 34–36, 1990

    PubMed  CAS  Google Scholar 

  • Israel DS, Stotka JL, Rock WL, Polk RE, Rogge MC et al. Effect of ciprofloxacin administration on warfarin response in adult subjects. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago. Sept 29–Oct 2, Abstract no. 599, 1991

  • Janknegt R. Drug interactions with quinolones. Journal of Antimicrobial Chemotherapy 26(Suppl. D): 7–29, 1990

    PubMed  CAS  Google Scholar 

  • Jolson HM, Tanner LA, Green L, Grasela TH. Adverse reaction reporting of interaction between warfarin and fluoroquinolones. Archives of Internal Medicine 151: 1003–1004, 1991

    Article  PubMed  CAS  Google Scholar 

  • Jüngst G, Weidmann E, Breitstadt A, Huppertz E. Does ofloxacin interact with NSAIDs to cause psychotic side effects? 17th International Congress of Chemotherapy, Berlin, June 23–28. Abstract no. 412, 1991

  • Kamada AK. Possible interaction between ciprofloxacin and warfarin. DICP: Annals of Pharmacotherapy 24: 27–28, 1990

    PubMed  CAS  Google Scholar 

  • Kara M, Hasinoff BB, McKay DW, Campbell NRC. Clinical and chemical interactions between iron preparations and ciprofloxacin. Britisch Journal of Clinical Pharmacology 31: 257–261, 1991

    Article  CAS  Google Scholar 

  • Karki SD, Bentley DW, Raghavan M. Seizure with ciprofloxacin and theophylline combined therapy. DICP: Annals of Pharmacotherapy 24: 595–596, 1990

    PubMed  CAS  Google Scholar 

  • Korten V, Barclas A, Tankurt E, Ozuner Z, Ulusoy N. Bismuthsubcitrate does not reduce the bioavailability of ciprofloxacin. 5th European Congress of Clinical Microbiology and Infectious Diseases, Oslo, September 9–11, Abstract 1701, 1991

  • Koup JR, Toothaker RD, Posvar E, Sedman AJ, Colburn WA. Theophylline dosage adjustment during enoxacin coadministration. Antimicrobial Agents and Chemotherapy 34: 803–807, 1990

    Article  PubMed  CAS  Google Scholar 

  • Krüger HU, Schuler U, Proksch B, Göbel M, Ehninger G. Investigation of potential interaction of ciprofloxacin with cyclosporin sporin in bone marrow transplant recipients. Antimicrobial Agents and Chemotherapy 34: 1048–1052, 1990

    Article  PubMed  Google Scholar 

  • Kunze K, Wienkers L, Trager W. The effect of lomefloxacin on the metabolism of the warfarin enantiomers by human liver microsomes. 17th International Congress of Chemotherapy, Berlin, June 23–28. Abstract no. 433, 1991

  • Lang J, Finaz de Villaine J, Garroffo R, Touraine JL. Cyclosporin (cyclosporin A): pharmacokinetics in renal transplant patients receiving ciprofloxacin. American Journal of Medicine 87(Suppl. 5A): 82S–85S, 1989

    Article  PubMed  CAS  Google Scholar 

  • LeBel M, Vallée F, St-Laurent M. Influence of lomefloxacin on the pharmacokinetics of theophylline. Antimicrobial Agents and Chemotherapy 34: 1254–1256, 1990

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Smith JT. 4-Quinolones and multivalent ions. Journal of Antimicrobial Chemotherapy 26: 149, 1990

    Article  PubMed  CAS  Google Scholar 

  • Linville D, Emory C, Graves L. Ciprofloxacin and warfarin interaction. American Journal of Medicine 90: 765, 1991

    PubMed  Google Scholar 

  • Lode H, Hampel B, Wachter T, Borner K, Koeppe P. Single dose pharmacokinetics of fleroxacin in volunteers, fasting after standard breakfast and antacids. International Congress of Chemotherapy, Jerusalem, June 21–26. Abstract no. W14, 1989

  • Lomaestro MB, Bailie GR. Effect of staggered dose of calcium on the bioavailability of ciprofloxacin. Antimicrobial Agents and Chemotherapy 35: 1004–1007, 1991

    Article  PubMed  CAS  Google Scholar 

  • Maggiolo F, Pellegata G, Marchetti G, Pravettoni G, Caprioli S, et al. Carbocystein effect on serum and sputum kinetics of ciprofloxacin. 5th European Congress of Clinical Microbiology and Infectious Diseases. Oslo, September 9–11, Abstract no. 1703, 1991

  • Mahr G, Sörgel F, Noje M, Gottschalk B, Granneman R, et al. The effect of temafloxacin and ciprofloxacin on the elimination of caffeine in healthy volunteers. 17th International Congress of Chemotherapy, Berlin, June 23–28. Abstract no. 417 1991

  • Mant T, Morrison P, Millar E. The lack of interaction between temafloxacin and acute administration of heparin. 17th International Congress of Chemotherapy, Berlin, June 23–28, Abstract no. 413, 1991

  • Mason B. Keep patient compliance in mind when assessing potential drug interactions. Hospital Formulary 26: 511–512, 1991

    Google Scholar 

  • Niki Y, Tasaki Y, Tsukijama K, Umekie S, Watanabe M, et al. Effect of NY-198 on the serum concentration of theophylline. Chemotherapy 36(Suppl. 2): 251–255, 1988

    Google Scholar 

  • Nix DE, DeVito JM, Whitbread MA, Schentag JJ. Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. Journal of Antimicrobial Chemotherapy 19: 263–269, 1987

    Article  PubMed  CAS  Google Scholar 

  • Nix DA, Schentag JJ. Lomefloxacin absorption kinetics when administered with ranitidine and sucralfate. Proceedings of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, Texas, September 11–16. Abstract 1276, 1989a

  • Nix DE, Wilton JH, Ronald B, Distlerath L, Williams VC. Inhibition of norfloxacin absorption by antacids. Antimicrobial Agents and Chemotherapy 34: 432–435, 1990

    Article  PubMed  CAS  Google Scholar 

  • Nix DE, Watson WA, Lener ME, Frost RW, Krol G, et al. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clinical Pharmacology and Therapeutics 46: 700–705, 1989b

    Article  PubMed  CAS  Google Scholar 

  • Nozaki M, Kohno K, Niwa M, Tanaki K, Tsurumi K. Comparative study of convulsions induced by concomitant intake of new quinolones and anti inflammatory drugs in mice. 17th International Conference of Chemotherapy, Berlin, June 23–28. Abstract no. 603, 1991

  • Okhamafe AO, Akerle JO, Chukuka CS. Pharmacokinetic interactions of norfloxacin with some metallic medicinal agents. International Journal of Pharmaceutics 68: 11–18, 1991

    Article  CAS  Google Scholar 

  • Okimoto N, Niki Y, Soezima R. Effect of DR-3355 on serum level of oral theophylline. 17th International Congress of Chemotherapy, Berlin. June 23–28. Abstract no. 409, 1991

  • Orme M, Back D, Millar E, Mant T. The lack of interaction between temafloxacin and oral contraceptive steroids (OCS). 17th International Congress of Chemotherapy. Berlin, June 23–28. Abstract no. 409, 1991

  • Parent M, LeBel M. Meta-analysis of quinolone-theophylline interactions. DICP: Annals of Pharmacotherapy 25: 191–194, 1991

    PubMed  CAS  Google Scholar 

  • Parent M, St-Laurent M, LeBel M. Safety of fleroxacin coadministered with theophylline to young and elderly volunteers. Antimicrobial Agents and Chemotherapy 34: 1249–1253, 1990

    Article  PubMed  CAS  Google Scholar 

  • Parpia SH, Nix DE, Heymanowski LG, Goldstein HR, Wilton JH, et al. Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrobial Agents and Chemotherapy 33: 99–102, 1989

    Article  PubMed  CAS  Google Scholar 

  • Polk RE, Drug-drug interactions with ciprofloxacin and other fluoroquinolones. American Journal of Medicine 87(Suppl. 5A): 76S–81S, 1989

    Article  PubMed  CAS  Google Scholar 

  • Polk RE, Healy DP, Sahai J, Drwal L, Racht E. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrobial Agents and Chemotherapy 33: 1841–1844, 1989

    Article  PubMed  CAS  Google Scholar 

  • Rindone JP, Keuey CL, Jones WN, Garewal HS. Hypothrobinemic effect of warfarin not influenced by ciprofloxacin. Clinical Pharmacy 10: 136–138, 1991

    PubMed  CAS  Google Scholar 

  • Robson RA, Begg EJ, Atkinson HC, Saunders DA, Frampton CM. Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline. British Journal of Clinical Pharmacology 29: 491–493, 1990

    Article  PubMed  CAS  Google Scholar 

  • Rocci ML, Vlasses PH, Distlerath LM, Gregg MH, Wheeler SC, et al. Norfloxacin does not alter warfarin’s disposition or anticoagulant effect. Journal of Clinical Pharmacology 30: 728–732, 1990

    PubMed  Google Scholar 

  • Rogge MC, Solomon WR, Sedman AJ, Welling PG, Toothaker RD, et al. The theophylline-enoxacin interaction: I effect of enoxacin dose size on theophylline disposition. Clinical Pharmacology and Therapeutics 44: 579–587, 1988

    Article  PubMed  CAS  Google Scholar 

  • Rubinstein E, Segev S. Drug interactions of ciprofloxacin with other non-antibiotic agents. American Journal of Medicine 82(Suppl. 4A): 119–123, 1987

    PubMed  CAS  Google Scholar 

  • Ryerson BA, Toothaker RD, Posvar EL, Sedman AJ, Koup JR. Effect of enoxacin on cyclosporine pharmacokinetics in healthy subjects. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 29–October 2. Abstract no. 597, 1991

  • Ryerson BA, Toothaker RD, Seelman AJ, Colbum W. Effect of sucralfate on enoxacin pharmacokinetics. Proceedings of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, Texas. Abstract no. 214, 1989

  • Sahai J, Oliveras L, Garber G. Effect of bismuthsubsalicylate and ciprofloxacin absorption: a preliminary investigation. 17th International Congress of Chemotherapy, Berlin, June 23–28. Abstract no. 414, 1991

  • Sano M, Kawakatsu K, Yamamoto I, Takeyama M, Yamashia H, et al. Inhibitory effect of enoxacin, ofloxacin and norfloxacin on renal excretion of theophylline in humans. European Journal of Clinical Pharmacology 36: 323–324, 1989

    Article  PubMed  CAS  Google Scholar 

  • Santais MC, Grossriether H, Callens E, Chauvain JP, Ruff F. Effect of temafloxacin on the pharmacokinetics of theophylline. 17th International Congress of Chemotherapy, Berlin, June 23–28, Abstract no. 407, 1991

  • Schwartz J, Jauregui L, Lettieri J, Bachmann K. Impact of ciprofloxacin on theophylline clearance and steady state concentrations in serum. Antimicrobial Agents and Chemotherapy 32: 75–77, 1988

    Article  PubMed  CAS  Google Scholar 

  • Seelman R, Mahr G, Sörgel F, Gottschalk B, Granneman R, et al. The effect of antacids and Cimetidine on the pharmacokinetics of temafloxacin. Proceedings of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, Texas. Abstract no. 215, 1989

  • Semel JD, Allen N. Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole. Southern Medical Journal 84: 465–468, 1991

    Article  PubMed  CAS  Google Scholar 

  • Shiba K, Okasaki O, Aoki H, Sakaj O, Shimada J. Inhibition of DR-3355 absorption by metal-ions. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 29–October 2. Abstract no. 594, 1991a

  • Shiba K, Saito A, Miyahara T, Tachizawa H, Fujimoto T. Effect of aluminium hydroxide on the pharmacokinetics of new quinolones in human. International Congress of Chemotherapy, Istanbul, July 19–24, Abstract no. 247, 1987

  • Shiba K, Saito A, Shimada J, Hori S, Kaji M. Interactions of fleroxacin with dried aluminum hydroxide gel and probenecid. Reviews of Infectious Diseases 11(Suppl. 5): 18–19, 1989

    Google Scholar 

  • Shiba K, Yoshida M, Kachi M, Shimada J, Saito A, et al. Effects of peptic ulcer healing drugs on the pharmacokinetics of a new quinolone ofloxacin. 17th International Congress of Chemotherapy, Berlin, June 23–28. Abstract no. 415, 1991b

  • Shintani S, Kusunoki A, Hosoki E, Yamashita S. Drug interaction of OPC-17116 a new quinolone antibacterial agent, with non-steroidal anti-inflammatory drugs in experimental animal. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 29–October 2. Abstract no. 1479, 1991

  • Shishido H, Matsumoto K, Nagatake T, Tabuchi S. Cross-over pharmacokinetics of NY-198 and ofloxacin in healthy volunteers and gastrectomized patients. Chemotherapy 36(S2): 256–264, 1988

    Google Scholar 

  • Sörgel F, Mahr G, Kinzig M, Buchal G, Noje M, et al. The influence of temafloxacin and ciprofloxacin on the elimination of caffeine in human volunteers. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 29–October 2. Abstract no. 588, 1991

  • Stroshane RM, Brown RR, Cook JA, Silverman MH. The effect of food, milk and antacid on the absorption of orally administered amifloxacin. 2nd International Symposium on New Quinolones, Geneva, August 25–27. Abstract no. 75, 1988

  • Takagi K, Yamaki K, Nadai M, Kuzuya T, Hasegawa T. Effect of a new quinolone, sparfloxacin, on the pharmacokinetics of theophylline in asthmatic patients. Antimicrobial Agents and Chemotherapy 35: 1137–1141, 1991

    Article  PubMed  CAS  Google Scholar 

  • Tan KKC, Allwood MC, Shawket S. Effect of ciprofloxacin on the pharmacokinetics of antipyrine in healthy volunteers. Journal of Clinical Pharmacy and Therapeutics 15: 151–154, 1990

    Article  PubMed  CAS  Google Scholar 

  • Torre D, Sampietro C, Rossi S, Bianchi W, Maggiolo F. Ciprofloxacin and activated charcoal, pharmacokinetic data. 2nd International Symposium on New Quinolones, Geneva, August 25–27. Abstract no. 71, 1988

  • Unseld E, Ziegler G, Gemeinhardt A, Janssen U, Klotz U. Possible interaction of fluoroquinolones with the benzodiazepine-GABAa-receptor complex. British Journal of Clinical Pharmacology 30: 63–67, 1990

    Article  PubMed  CAS  Google Scholar 

  • Upton RA. Pharmacokinetic interactions between theophylline and other medications (Part I). Clinical Pharmacokinetics 20: 66–80, 1991

    Article  PubMed  CAS  Google Scholar 

  • Valero F, DeLaTorre R, Segura J. Selective in vitro inhibition of hepatic oxidative metabolism by quinolones: 7-ehthoxyreso-rufin and caffeine as model substrates. Journal of Pharmacy and Pharmacology 43: 17–21, 1991

    Article  PubMed  CAS  Google Scholar 

  • Van Saene JJM. Colonic delivery of polymyxine E and four quinolones for flora suppression, Thesis, State University Groningen 1990

    Google Scholar 

  • Van Slooten AD, Nix DE, Wilton JH, Love JH, Spivey JM, et al. Combined use of ciprofloxacin and sucralfate. DICP: Annals of Pharmacotherapy 25: 578–581, 1991

    PubMed  Google Scholar 

  • Verho M, Malerczyk V, Rosenkranz B, Grötsch H. Absence of interaction between ofloxacin and phenprocoumon. Current Medical Research and Opinion 10: 474–479, 1987

    Article  PubMed  CAS  Google Scholar 

  • Vinceneux P, Weber P, Boussougant Y, Chanteclair G, Gres JJ. Pefloxacin and silicone containing gastric cytoprotective agents. 2nd International Symposium on New Quinolones, Geneva, August 25–27. Abstract no. 19, 1988

  • Vollaard EJ, The concept of colonization reistance, Thesis, Catholic University, Nijmegen, 1991

    Google Scholar 

  • Weber P, Bossongaut Y, Vinceneus P. Reduced internal absorption of pefloxacin in the presence of antacid. International Congress of Chemotherapy, Istanbul. Abstract no. 290, 1987

  • Wijnands WJA, Vree TB, Baars AM, Van Herwaarden CLA. The influence of 4-quinolones: ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline. Pharmaceutisch Weekblad — Scientific Edition 9 (Suppl.): S72–S75, 1987a

    Article  PubMed  Google Scholar 

  • Wijnands GJA, Vree TB, Janssen TJ, Guelen PJM. Drug-drug interactions affecting fluoroquinolones. American Journal of Medicine 87(Suppl. 6C): 47S–51S, 1989

    PubMed  CAS  Google Scholar 

  • Winn MJ, Park BK, Breckenridge AM. The effects of lomefloxacin on the cytochrome P-450 mediated metabolism of tolbutamide, ethinyloestradiol and mianserin in human liver microsomes. International Congress of Infectious Diseases, Montreal, July 15–19. Abstract no. 290, 1990

  • Wyld P, Nimmo W, Millar E, Coles S. The lack of potentiation of the anticoagulant effect of warfarin when administered concurrently with temafloxacin. 17th International Congress of Chemotherapy, Berlin, June 23–28. Abstract 686, 1991

  • Yuk JH, Nightgale CN, Quintiliani R. Ciprofloxacin levels when receiving sucralfate. Journal of the American Medical Association 262: 901, 1989

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy and Pharmacokinetics, Tjongerschans General Hospital, Heerenveen, The Netherlands

    Jacobus R. B. J. Brouwers

  2. University Center for Pharmacy, Department of Pharmacology and Therapeutics, State University, Groningen, The Netherlands

    Jacobus R. B. J. Brouwers

Authors
  1. Jacobus R. B. J. Brouwers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brouwers, J.R.B.J. Drug Interactions with Quinolone Antibacterials. Drug-Safety 7, 268–281 (1992). https://doi.org/10.2165/00002018-199207040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199207040-00003

Keywords

Search

Navigation